178 related articles for article (PubMed ID: 30251115)
1. Standardization of [F-18]FDG PET/CT for response evaluation by the Radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multicenter phase II trial.
Bae H; Tsuchiya J; Okamoto T; Ito I; Sonehara Y; Nagahama F; Kubota K; Tateishi U
Jpn J Radiol; 2018 Nov; 36(11):686-690. PubMed ID: 30251115
[TBL] [Abstract][Full Text] [Related]
2. Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET/CT for evaluating diffuse large B cell lymphoma.
Daisaki H; Tateishi U; Terauchi T; Tatsumi M; Suzuki K; Shimada N; Nishida H; Numata A; Kato K; Akashi K; Harada M
Ann Nucl Med; 2013 Apr; 27(3):225-32. PubMed ID: 23264065
[TBL] [Abstract][Full Text] [Related]
3. Optimization of image reconstruction conditions with phantoms for brain FDG and amyloid PET imaging.
Akamatsu G; Ikari Y; Nishio T; Nishida H; Ohnishi A; Aita K; Sasaki M; Sasaki M; Senda M
Ann Nucl Med; 2016 Jan; 30(1):18-28. PubMed ID: 26337533
[TBL] [Abstract][Full Text] [Related]
4. The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy.
Kinahan PE; Perlman ES; Sunderland JJ; Subramaniam R; Wollenweber SD; Turkington TG; Lodge MA; Boellaard R; Obuchowski NA; Wahl RL
Radiology; 2020 Mar; 294(3):647-657. PubMed ID: 31909700
[TBL] [Abstract][Full Text] [Related]
5. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.
Minamimoto R; Fayad L; Advani R; Vose J; Macapinlac H; Meza J; Hankins J; Mottaghy F; Juweid M; Quon A
Radiology; 2016 Jul; 280(1):220-9. PubMed ID: 26854705
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.
Makris NE; Huisman MC; Kinahan PE; Lammertsma AA; Boellaard R
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1507-15. PubMed ID: 23754762
[TBL] [Abstract][Full Text] [Related]
7. Multicentre analysis of PET SUV using vendor-neutral software: the Japanese Harmonization Technology (J-Hart) study.
Tsutsui Y; Daisaki H; Akamatsu G; Umeda T; Ogawa M; Kajiwara H; Kawase S; Sakurai M; Nishida H; Magota K; Mori K; Sasaki M;
EJNMMI Res; 2018 Aug; 8(1):83. PubMed ID: 30128776
[TBL] [Abstract][Full Text] [Related]
8. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
[TBL] [Abstract][Full Text] [Related]
9. Clinical respiratory motion correction software (reconstruct, register and averaged-RRA), for
Bouyeure-Petit AC; Chastan M; Edet-Sanson A; Becker S; Thureau S; Houivet E; Vera P; Hapdey S
Br J Radiol; 2017 Feb; 90(1070):20160549. PubMed ID: 27936893
[TBL] [Abstract][Full Text] [Related]
10. Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.
Rausch I; Bergmann H; Geist B; Schaffarich M; Hirtl A; Hacker M; Beyer T
Nuklearmedizin; 2014; 53(6):242-8. PubMed ID: 25131649
[TBL] [Abstract][Full Text] [Related]
11. Quantitative imaging characteristics of zirconium-89 on Gemini Time-Of-Flight PET/CT.
Alanazi SF; Alzimami KS; Ghannam MM; Aljammaz IJ; Alrumayan F; Sassi SA
Nucl Med Commun; 2016 Dec; 37(12):1238-1245. PubMed ID: 27749774
[TBL] [Abstract][Full Text] [Related]
12. Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology.
Ziai P; Hayeri MR; Salei A; Salavati A; Houshmand S; Alavi A; Teytelboym OM
Radiographics; 2016; 36(2):481-96. PubMed ID: 26963458
[TBL] [Abstract][Full Text] [Related]
13. MO-D-218-01: Overview of Methodology and Standards (QIBA, IEC, AIUM and AAPM).
Carson P
Med Phys; 2012 Jun; 39(6Part21):3869-3870. PubMed ID: 28518282
[TBL] [Abstract][Full Text] [Related]
14. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
Kurland BF; Muzi M; Peterson LM; Doot RK; Wangerin KA; Mankoff DA; Linden HM; Kinahan PE
J Nucl Med; 2016 Feb; 57(2):226-30. PubMed ID: 26493206
[TBL] [Abstract][Full Text] [Related]
15. Harmonization based on quantitative analysis of standardized uptake value variations across PET/CT scanners: a multicenter phantom study.
Monsef A; Ay MR; Sheikhzadeh P; Geramifar P; Rahmim A; Ghafarian P
Nucl Med Commun; 2022 Sep; 43(9):1004-1014. PubMed ID: 35836388
[TBL] [Abstract][Full Text] [Related]
16. Comparison between new-generation SiPM-based and conventional PMT-based TOF-PET/CT.
Wagatsuma K; Miwa K; Sakata M; Oda K; Ono H; Kameyama M; Toyohara J; Ishii K
Phys Med; 2017 Oct; 42():203-210. PubMed ID: 29173917
[TBL] [Abstract][Full Text] [Related]
17. Treatment response evaluation with
Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
[TBL] [Abstract][Full Text] [Related]
18. Normal model construction for statistical image analysis of torso FDG-PET images based on anatomical standardization by CT images from FDG-PET/CT devices.
Takeda K; Hara T; Zhou X; Katafuchi T; Kato M; Ito S; Ishihara K; Kumita S; Fujita H
Int J Comput Assist Radiol Surg; 2017 May; 12(5):777-787. PubMed ID: 28168681
[TBL] [Abstract][Full Text] [Related]
19. Use of a digital phantom developed by QIBA for harmonizing SUVs obtained from the state-of-the-art SPECT/CT systems: a multicenter study.
Nakahara T; Daisaki H; Yamamoto Y; Iimori T; Miyagawa K; Okamoto T; Owaki Y; Yada N; Sawada K; Tokorodani R; Jinzaki M
EJNMMI Res; 2017 Dec; 7(1):53. PubMed ID: 28639254
[TBL] [Abstract][Full Text] [Related]
20. The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma).
Chauvie S; Bergesio F; Fioroni F; Brambilla M; Biggi A; Versari A; Guerra L; Storto G; Musto P; Luminari S; Cabras MG; Balzarotti M; Rigacci L; Martelli M; Vitolo U; Federico M; Gallamini A
Phys Med; 2016 May; 32(5):651-6. PubMed ID: 27133138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
